Join us and participate in the new developments in medicine
General Eligibility
Clinical Trials
Filter by enrollment status to find studies that may be right for you. We value your participation in advancing prostate cancer care.
Status: Active, Not Enrolling
The CAPTAIN study is evaluating novel treatment approaches for patients with prostate cancer. Researchers are investigating whether these therapies can improve disease control and expand treatment options while maintaining quality of life.
Status: Active and Enrolling
The CARE study is investigating new approaches for the treatment and management of prostate cancer. The goal of this research is to improve patient outcomes and provide additional therapeutic options for men with prostate cancer.
Status: Active and Enrolling
The Curium study is evaluating advanced PET imaging technology designed to improve the detection and staging of prostate cancer. This research may help physicians make more informed treatment decisions and better understand disease progression.
Status: Active and Enrolling
The CLARIFY study is evaluating the use of Copper-64 SAR-bisPSMA PET imaging in men with high-risk prostate cancer. Researchers hope this imaging technology will improve the detection of lymph node involvement and assist in treatment planning.
Status: Active, Not Enrolling
The PYLARIFY Registry is evaluating the real-world clinical utility of PYLARIFY PET imaging in patients with prostate cancer. Researchers aim to better understand how PSMA PET imaging influences treatment decisions and long-term outcomes.
Status: Active, Not Enrolling
The Amplify study is evaluating new treatment combinations for prostate cancer with the aim of improving disease control and patient outcomes. Researchers are studying the safety and effectiveness of these therapies in appropriate patients.
Status: Active, Not Enrolling
The Vapor study is investigating innovative treatment strategies for prostate cancer. Researchers are studying the safety and effectiveness of these approaches with the goal of improving outcomes for patients.
Status: Active and Enrolling
The Vanquish study is evaluating novel therapies for prostate cancer. Researchers aim to determine whether these treatments can provide additional options and improve outcomes for patients.
Status: Coming Soon
The Artera study will evaluate precision medicine tools designed to help personalize treatment decisions for men with prostate cancer. Researchers hope this approach will allow therapies to be tailored more effectively to each patient.
Eligibility criteria vary depending on the study. Patients may qualify for one or more clinical trials if they meet certain study-specific requirements. For additional study requirements and eligibility information, please contact our Research Department by emailing research@theupi.com or calling 210-617-3670 and selecting the Research option. A member of our team will be happy to answer your questions and discuss available study opportunities.
